Abstract
Therapeutic gene delivery systems offer the potential for the treatment of a range of inherited and acquired inherited diseases. In contrast with viral gene vectors, the nonviral gene vectors provide a safer alternative and additional advantage such as the improved delivery efficiency, low cost, and often unlimited capacity to package DNA. Here we describe preparation of nonviral gene delivery technique based on lipid:peptide:DNA (LPD) complexes. The size of LPD particles is in the nanometre range. The use of these nanoparticulate LPDs results in high efficiency transfections and a high level of gene expression in vitro. LPDs provide a convenient and efficient tool for gene therapy for the gene delivery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Emery DE (2004) Gene therapy for genetic diseases: on the horizon. Clin Appl Immunol Rev 4:411–422
Hashida M, Nishikawa M, Yamashita F, Takakura Y (2001) Cell-specific delivery of genes with glycosylated carriers. Adv Drug Deliv Rev 52:187–196
Schwiebert EM, Boyd C, Scholte BJ (2004) Gene delivery systems-gene therapy vectors for cystic fibrosis. J Cystic Fibrosis 3:203–212
Patel DH, Misra A (2011) Gene delivery using viral vectors. Challenges Deliv Ther Gen Proteom 5:207–270
Lee RJ, Huang L (1997) Lipidic vector systems for gene transfer. Crit Rev Ther Drug Carrier Syst 14:173–206
Park TG, Jeong JH, Kim SW (2006) Current status of polymeric gene delivery systems. Adv Drug Deliv Rev 58:467–486
Pouton CW, Seymour LW (2001) Key issues in non-viral gene delivery. Adv Drug Deliv Rev 46:187–203
Liu F, Huang L (2002) Development of non-viral vectors for systemic gene delivery. J Control Release 78:259–266
Woodle MC, Scaria P (2001) Cationic liposomes and nucleic acids. Curr Opin Colloid Interface Sci 6:78–84
Zabner J (1997) Cationic lipids used in gene transfer. Adv Drug Deliv Rev 27:17–28
Pedroso de Lima MC, Simões S, Pires P, Faneca H, Düzgüne N (2001) Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv Drug Deliv Rev 47:277–294
Zhdanov RI, Podobed OV, Vlassov VV (2002) Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy. Bioelectrochemistry 58:53–64
Morille M, Passirani C, Vonarbourg A, Clayreul A, Benoit JP (2008) Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 29:3477–3496
Moret I, Peris E, Guillem VM, Benet M, Revert F, Dasà F, Crespo A, Aliño SF (2001) Stability of PEI–DNA and DOTAP–DNA complexes: effect of alkaline pH, heparin and serum. J Control Release 76:169–181
Remaut K, Sanders NN, Fayazpour F, Demeester J, DeSmedt SC (2006) Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes. J Control Release 115:335–343
Ahearn A, Malone R (1999) Models of cationic liposome mediated transfection. Gene Ther Mol Biol 4:159–170
Zauner W, Farrow NA, Haines AM (2001) In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J Control Release 71:39–51
Tsai JT, Furstoss KJ, Michnick T, Sloane DL, Paul RW (2002) Quantitative physical characterization of lipid-polycation-DNA lipoplexes. Biotechnol Appl Biochem 36:13–20
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Zhang, F., Li, HY. (2012). Preparation of Lipid:Peptide:DNA (LPD) Nanoparticles and Their Use for Gene Transfection. In: Soloviev, M. (eds) Nanoparticles in Biology and Medicine. Methods in Molecular Biology, vol 906. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-953-2_27
Download citation
DOI: https://doi.org/10.1007/978-1-61779-953-2_27
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-952-5
Online ISBN: 978-1-61779-953-2
eBook Packages: Springer Protocols